This morning, Lilly announced the retirement of CEO John Lechleiter, who’ll be succeeded on January 1, 2017, by Dave Ricks. Dave is a Lilly veteran: With us for 20 years, he’s led affiliates in the U.S., Canada and China, and currently heads our Bio-Medicines unit.
At a press conference at Lilly Corporate Center earlier today, John joined Bart Peterson, Senior Vice President of Corporate Affairs and Communications, to announce Dave’s new role. “Dave is well-suited to help Lilly capitalize on the opportunities before it, as well as to confront the inevitable challenges,” said John. “He will provide outstanding leadership for our company, and in our community, in the coming years.”
You can watch the full announcement here: